Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

Not Applicable

• Conditions: Erectile Dysfunction
• Interventions: Diagnostic Test: Endocan; Drug: tadalafil

• Registration Number: NCT05109377
• Lead Sponsor: Ankara Training and Research Hospital

Brief Summary

The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

Detailed Description

The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.

Study Timeline

• Study Start: 2021-06-24
• Study First Submitted: 2021-09-04
• Status Verified: 2021-11
• Study First Submitted QC: 2021-11-04
• Last Update Submitted: 2021-11-04
• Study First Posted: 2021-11-05
• Last Update Posted: 2021-11-05
• Primary Completion: 2021-11-15
• Study Completion: 2021-12-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 90

Inclusion Criteria

• Patients with erectile dysfuction

Read More

Exclusion Criteria

• Psychogenic erectile dysfunction
• Erectile dysfunction associated with hormonal disorders
• Drug related erectile dysfunction

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
5mg tadalafil	Endocan	5mg tadalafil
5mg tadalafil	tadalafil	5mg tadalafil
20mg tadalafil	Endocan	20 mg tadalafil
20mg tadalafil	tadalafil	20 mg tadalafil

Primary Outcome Measures

Name	Time	Method
Rates of IIEF Score	1 month	Levels of Endocan relationship with IIEF

Secondary Outcome Measures

Name	Time	Method
Levels of Endocan	1 month	Levels of Endocan with tadalafil treatment

Trial Locations

Locations (1)

Veysel Bayburtluoğlu; 🇹🇷 Ankara, Turkey